Financials
Financial year 2025
La Fédération du Conseil International des Excipients Pharmaceutiques from Brussel, company number BE0823931361, closed financial year 2025 with a result of € 17,581 after tax. For that financial year La Fédération du Conseil International des Excipients Pharmaceutiques recorded a gross margin of € 18,187 and equity of € 153,418. Compared with financial year 2024, the result moved from € -2,756 to € 17,581. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 10, 2026.
€ 153,418
▲ 13% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 17,581
▲ still € 2,756 loss in 2024
Profit after tax over the fiscal year.
€ 152,292
▲ 15% vs 2024
Cash and bank balances on the last day of the fiscal year.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 8
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -106 | € 25,530 | € -1,889 | € 18,187 | ▲ € 20,076 |
| Profit after taxes | € -560 | € 25,217 | € -2,756 | € 17,581 | ▲ € 20,337 |
| Equity | € 113,375 | € 138,592 | € 135,836 | € 153,418 | ▲ 13% |
| Total debts | € 26,441 | € 9,723 | € 0 | € 1,508 | |
| Cash | € 113,656 | € 119,392 | € 132,483 | € 152,292 | ▲ 15% |
| Retained profit | € 53,350 | € 78,567 | € 75,812 | € 93,393 | ▲ 23% |
| Balance sheet total | € 139,815 | € 148,315 | € 135,836 | € 154,925 | ▲ 14% |
Key figures of La Fédération du Conseil International des Excipients Pharmaceutiques, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to La Fédération du Conseil International des Excipients Pharmaceutiques?
What happened at La Fédération du Conseil International des Excipients Pharmaceutiques in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 17,581. Source: NBB ↗
- Start of the company according to the CBE. KBO
In short
From € 560 loss in 2022 to € 17,581 profit in 2025.
Best year ever: 2023, with € 25,217 profit.
A new publication or filing at La Fédération du Conseil International des Excipients Pharmaceutiques? We notify you, reason included.
Follow La Fédération du Conseil International des Excipients PharmaceutiquesDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind La Fédération du Conseil International des Excipients Pharmaceutiques are Le Conseil International des Excipients Pharmaceutiques (IPEC Europe), International Pharmaceuticals Excipients Council of Japan (IPEC Japan) and International Pharmaceuticals Excipients Council of the Americas (IPEC Americas).
Directors
According to the 2025 annual accounts
Le Conseil International des Excipients Pharmaceutiques (IPEC Europe)
Chairman of the board
International Pharmaceuticals Excipients Council of Japan (IPEC Japan)
Director
International Pharmaceuticals Excipients Council of the Americas (IPEC Americas)
Vice-chairman of the board
Establishments
Establishment units
Physical locations of this company
Maria van Bourgondiëstraat 52
1000 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
All companies at this address →EUROCITY
€ 1.8 million gross margin · 2025
Stichting Wereld Dorpen voor Kinderen
€ 453,380 gross margin · 2025
FEDERATION EUROPEENNE DE L'INDUSTRIE DU SPORT
€ 620,228 gross margin · 2024
Le Conseil International des Excipients Pharmaceutiques - Europe same network
€ 412,996 gross margin · 2025
Eurocity Holdings
€ 1.4 million gross margin · 2025
+2 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0823.931.361
- VAT number
- BE 0823.931.361
- Registered office
- Maria van Bourgondiëstraat 52, 1000 Brussel
- Names & denominations
- La Fédération du Conseil International des Excipients Pharmaceutiques · IPEC Federation
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 15 March 2010
- Peppol
- Active · Active since 5 Dec 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Markt- en opinieonderzoek
Organisatie van congressen en beurzen